Photo from wikipedia
Gemcitabine combined with platinum is currently the recommended first‐line chemotherapy for advanced non‐small cell lung cancer (NSCLC). This study aimed to quantitatively compare the efficacy and safety of gemcitabine‐platinum combinations… Click to show full abstract
Gemcitabine combined with platinum is currently the recommended first‐line chemotherapy for advanced non‐small cell lung cancer (NSCLC). This study aimed to quantitatively compare the efficacy and safety of gemcitabine‐platinum combinations in the treatment of advanced NSCLC under different dosing regimens based on extensive literature data.
Keywords:
non small;
combined platinum;
small cell;
gemcitabine combined;
gemcitabine;
cell lung
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!